ClinicalTrials.gg
RecruitingNCT07290881Updated Apr 21, 2026

Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery

An interventional study of Patient group who underwent ilioinguinal/iliohypogastric block and Patient group who underwent anterior iliac block in Acute Pain, sponsored by Harran University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by Harran University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 158 studies in Acute Pain with a site in Turkey — 23 open to participants now, 26 under way, none of them phase 3. Acute Pain · Turkey.

Planned enrollment
93rd of 135
60 · median 80
Started
2026
with 14 others
No phase
130 of 158
19 open now
Primary completion
2026-09
later than 15 of 25 live
Registered
138th of 158
by date

Among the 158 studies in Acute Pain with a site in Turkey, this one is the 93rd largest by planned enrollment of the 135 interventional ones that give a count, is one of 15 that started in 2026, is one of 130 with no phase, reaches primary completion later than 15 of the 25 other live ones, and was the 138th registered.

Acute Pain

1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.

Browse Acute Pain studies →

Open to participants now

23 of the 158 studies in Acute Pain with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 158 studies in Acute Pain with a site in Turkey, or all of them as a file.
02

Study summary

The primary aim of this study is to compare two postoperative analgesia techniques used in patients undergoing inguinal hernia surgery-(1) the anterior iliac block and (2) the ilioinguinal/iliohypogastric block-in terms of postoperative analgesia duration and patient satisfaction.

Effective postoperative analgesia in inguinal hernia surgery is crucial for improving patient comfort and reducing opioid consumption. Although ilioinguinal and iliohypogastric nerve blocks are commonly used for this purpose, their relatively limited dermatomal coverage may result in inadequate analgesia in some cases. The recently described Anterior Iliac Block has been proposed as an alternative to conventional techniques, offering potentially wider neural spread and more effective postoperative pain control. However, the efficacy and safety of this novel block have not yet been sufficiently evaluated in the literature.

Read the detailed description

The primary aim of this study is to compare two postoperative analgesia techniques used in patients undergoing inguinal hernia surgery-(1) the anterior iliac block and (2) the ilioinguinal/iliohypogastric block-in terms of postoperative analgesia duration and patient satisfaction.

Effective postoperative analgesia in inguinal hernia surgery is crucial for improving patient comfort and reducing opioid consumption. Although ilioinguinal and iliohypogastric nerve blocks are commonly used for this purpose, their relatively limited dermatomal coverage may result in inadequate analgesia in some cases. The recently described anterior iliac block has been proposed as an alternative to conventional techniques, offering potentially wider neural spread and more effective postoperative pain control. However, the efficacy and safety of this novel block have not yet been sufficiently evaluated in the literature.

This study aims to compare the anterior iliac block with the ilioinguinal/iliohypogastric block in terms of postoperative pain control and patient satisfaction. The objective is to determine whether the anterior iliac block, through its broader dermatomal distribution, provides lower NRS pain scores, reduced analgesic requirements, and higher patient satisfaction compared with traditional nerve blocks.

03

Conditions studied

  • Acute Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • It includes patients aged 18-65 years
  • Classified as
  • Who are undergoing elective inguinal hernia surgery

Exclusion criteria

Exclusion Criteria:

  • Patients who did not wish to participate voluntarily
  • Those with to the anterior iliac block or the Ilioinguinal/Iliohypogastric block,
  • Pregnant or breastfeeding women
  • Patients classified as -V
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Patient group who underwent anterior iliac block

    In this patient group, an anterior iliac block will be administered in the postoperative period, and postoperative pain at the surgical site will be assessed.

    Other: Patient group who underwent anterior iliac block

  • Active comparator
    Patient group who underwent ilioinguinal-iliohypogastric block

    In this patient group, an ilioinguinal-iliohypogastric block will be administered in the postoperative period, and postoperative pain at the surgical site will be assessed.

    Other: Patient group who underwent ilioinguinal/iliohypogastric block

Interventions

  • OtherPatient group who underwent ilioinguinal/iliohypogastric block

    Patient group who underwent ilioinguinal/iliohypogastric block

  • OtherPatient group who underwent anterior iliac block

    Patient group who underwent anterior iliac block

06

What researchers measure

Primary outcomes

  1. Akut ağrı (Sayısal Derecelendirme Ölçeği-NRS)

    The score is rated on a scale from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain.

    Time frame: 0-1-3-6-12-24 Hours

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Sep 2026, 4 months after the start.

Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2025
First posted
Dec 18, 2025
StartActual
Apr 20, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
Sep 1, 2026
Last update
Apr 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07290881
Lead sponsor
Harran University
Responsible party
ABDULHAKİM ŞENGEL (SPECİALİST, MD, ANESTHESİOLOGY AND REANİMATİON, Harran University) — Principal investigator
First posted
Dec 18, 2025
Start date
Apr 20, 2026
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Apr 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion